Patent ID: 8524732

Claim:
Compounds of the formula I in which R 1 denotes H, A, Hal, SA, (CH 2 ) p CN, SCN, (CF 2 ) p CF 3 , SF 5 , OA, O(CF 2 ) p CF 3 , S(CF 2 ) p CF 3 , NR 2 , NRCOR, NRSO 2 R, NR(CH 2 ) p NR 2 , CONR(CH 2 ) p NR 2 , SO 2 NR(CH 2 ) p NR 2 , CONR 2 , SO 2 NR 2 , or COOR, R 2 denotes H or Hal R 3 denotes H or A A denotes linear or branched alkyl having 1 to 10 C atoms or cycloalkyl having 3 to 7 C atoms, R 4 denotes aryl or heteroaryl, each of which is optionally substituted by Hal, NO 2 , CN, OR, A, —(CY 2 ) n —OR, —OCOR, —(CY 2 ) n —CO 2 R, —(CY 2 ) n —CN or —(CY 2 ) n —NR 2 , or R 4 denotes aryl or heteroaryl each of which is unsubstituted or mono- or polysubstituted by aryl or heteroaryl, where each of the optional aryl or heteroaryl substituents are optionally substituted by Hal, NO 2 , CN, A, OR, OCOR, NR 2 , CF 3 , OCF 3 , OCH(CF 3 ) 2 , X denotes O, Y denotes H, A, Hal or OR R denotes H, A, (CH 2 ) p O(CH 2 ) p R 3 or (CH 2 ) p NA(CH 2 ) p R 3 , W denotes CH 2 , C═O or C═S, Q 1 denotes NR, O or S, Z denotes —SO—, Q 2 denotes NR, S, O or a single bond, R 5 denotes H, (CY 2 ) p NR 2 , (CY 2 ) p OR, (CY 2 ) p SR, (CY 2 ) p Q 1 COQ 1 R or (CY 2 ) p COOR and, if Q 2 denotes a single bond, also Hal, Hal denotes F, Br or Cl n denotes 1, 2, 3 or 4, m denotes 0, 1 or 2, p denotes 0, 1, 2, 3, 4, 5, 6, 7 or 8 and s denotes 0, 1 or 2, and pharmaceutically usable tautomers, salts and stereoisomers thereof, including mixtures thereof in all ratios.